Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / General / General / March 2006

Tip: Looking for answers? Try searching our database.

Early-intervention therapies needed for Alzheimer's disease

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
HealthInfo - 21 Mar 2006 04:23 GMT
Reseachers show that dendritic spine density, impaired long-term
potentiation (LTP), and behavioral deficits occurred months before
plaque deposition in the Tg2576 mouse model of Alzheimer's disease.

The findings of this study highlight the importance that
early-intervention therapies will have in the treatment of
Alzheimer's disease.

Jacobsen et al. (2006) Early-onset behavioral and synaptic deficits in
a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA,
10.1073/pnas.0600948103.

The question is: Where are those early-intervention therapies?

-----------

Health Information
http://click2health.webmedtoday.com

Latest Medical Discoveries
http://aims.webmedtoday.com
RArmant - 21 Mar 2006 17:10 GMT
>Reseachers show that dendritic spine density, impaired long-term
>potentiation (LTP), and behavioral deficits occurred months before
[quoted text clipped - 9 lines]
>
>The question is: Where are those early-intervention therapies?

Let me rephrase the question -- What would those early-intervention
therapies be?

To name a few:

DHA at about 1.5g per 1000Cal consumed.

Purified EGCG at about 14mg/Kg(BW) per day
in divided doses. Teavigo is purified EGCG.

Curcumin at about a couple of hundred mg/day.

R-lipoic acid at about 600mg/day in divided doses
along with acetyl-l-carnitine at about 2 or 3 g/day
in a divided dose.

Ibuprofen appears to be among the best NSAIDs
to slow Alzheimer's. It does have its dangers. At low
doses it can cause stomach ulcers and at higher
doses produce kidney and liver damage.
timothytn@my-deja.com - 22 Mar 2006 00:46 GMT
NFT's occur years before overt AD in humans. A study in men aged 55-64
found ~75% of them had NFT's in parts of their brain. This may be when
the prodromal period of the disease i.e., well before age 55.
timothytn@my-deja.com - 22 Mar 2006 01:04 GMT
Ann Neurol. 1985 Mar;17(3):273-7. Related Articles, Links

Alzheimer changes in nondemented patients younger than sixty-five:
possible early stages of Alzheimer's disease and senile dementia of
Alzheimer type.

Ulrich J.

Senile plaques (SP) and neurofibrillary tangles (NFT) were found in 38
(74.5%) of 51 unselected brains of nondemented patients who died
between the ages of 55 and 64 years. A high proportion (22, or 43%) had
only NFTs. These were consistently present in the entorhinal cortex
and/or the hippocampus; the olfactory bulb, the amygdala, and the
nucleus basalis of Meynert were also occasionally involved. Isolated
SPs were seen in only 3 brains (6%); SPs and NFTs coexisted in 13
(25.5%). The distribution patterns of NFTs and SPs differed. NFTs were
seen in discrete, mostly single neurons of the structure, already
noted, whereas SPs occurred in a more generalized distribution over the
base and convexity of the cerebrum. The plaques were usually small (30
mu in diameter) and consisted of delicate fibrillary material. Other
types of SP were also seen. The incidence of various types of plaques
in nondemented patients is considered to indicate a morphological
evolution of these structures.

PMID: 3994315 [PubMed - indexed for MEDLINE]
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.